UniSuper makes first venture capital foray with $75 million funding

John Pearce, Chief Investment Officer at UniSuper

UniSuper, the $106 billion fund open to all Aussies, announced it has secured an investment relationship with Australia’s early-stage commercialisation fund manager – Uniseed.

Uniseed focuses on innovative programs that will change the world for the better. Founded in 2000 and owned by the Universities of Melbourne, Queensland, Sydney, NSW and the CSIRO, Uniseed provides seed funding for research and tech developed by its five partners. These innovative firms provide around half of all patents created by research firms in Australia.

Why did UniSuper opt to partner with Uniseed?

UniSuper’s Chief Investment Officer John Pearce says that Uniseed was a natural fit and logical choice for the fund. “UniSuper has always championed Aussie’s thinkers, creators and investigators. Uniseed is at the forefront of new start-ups and technologies,” Mr Pearce said.

“This is an excellent opportunity for UniSuper to actively participate in the development and commercialisation of research and technology through different innovators that will shape the future. We look forward to seeing this investment blossom and grow over time”.

Under the agreement, UniSuper has committed $75 million into Uniseed which will cover existing projects as well as exciting new developments across industries of the future, such as biotechnology, pharmaceuticals, quantum computing and green energy.

What will UniSuper’s investment be used for?

Uniseed’s Chief Executive Officer Peter Devine said that UniSuper’s investment will unlock more engagement with Australia’s growing innovation and start-up sector.

“UniSuper is one of Australia’s largest and most respected and innovative super funds, and the capital at its disposal will go a long way to ensuring we can seize opportunities presented by the brilliant minds at Australia’s top research organisations,” Dr Devine said.

 “This is a further step Uniseed is taking to facilitate commercialisation of Australian research. Today’s emergent start-ups are tomorrow’s tech and health giants, and with funding from UniSuper we are able to get in at the very early stages of these journeys.”

 The investments will feed into UniSuper’s sustainable investment options.